Preliminary evaluation of a dual chamber pacemaker with bradycardia diagnostic functions.

Unexplained Syncope is the main indication for the implantation of a diagnostic pacemaker. Studies on those implanted have shown that in patients with unexplained syncope, the diagnosis of paroxysmal bradycardia was feasible and reliable. The present study was designed to evaluate a new bradycardia...

Descripción completa

Detalles Bibliográficos
Publicado en:Pacing & Clinical Electrophysiology Vol. 18; no. 9; pp. 1636 - 1644
Autores principales: Lascault G, Barnays C, Cazeau S, Frank R, Medvedowsky JL
Formato: Journal Article
Publicado: Wiley-Blackwell Sep1995
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106038244&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106038244
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01478389
        4F8
      jtl: Pacing & Clinical Electrophysiology
      issn: 01478389
      maglogo: Y
    pubinfo:
      dt: Sep1995
      vid: 18
      iid: 9
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        106038244
        106038244
        2009414128
        10.1111/j.1540-8159.1995.tb06985.x
        NLM7491307
        106038244
      ppf: 1636
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Preliminary evaluation of a dual chamber pacemaker with bradycardia diagnostic functions.
      aug:
        au:
          Lascault G
          Barnays C
          Cazeau S
          Frank R
          Medvedowsky JL
      sug:
      ab: Unexplained Syncope is the main indication for the implantation of a diagnostic pacemaker. Studies on those implanted have shown that in patients with unexplained syncope, the diagnosis of paroxysmal bradycardia was feasible and reliable. The present study was designed to evaluate a new bradycardia diagnosis algorithm, loaded in a dual chamber pacemaker, in 24 patients considered as candidates for diagnostic pacemakers. During a mean follow-up of 253 days, at least one bradycardia episode was recorded in 13 patients. The mean number of detected bradycardias was 6 and the median was 3. The mean delay between the algorithm activation and the first bradycardia episode was 67 days. The mechanism of bradycardia was atrioventricular block in 6 patients, sin us node dysfunction in 6 patients, and consecutive blocked atrial premature beats in 2 patient, as indicated by the event markers. In 11 patients bradycardia was recorded during the daytime only or day and night. In two patients the episodes were recorded only at night. Overall, the algorithms was well-tolerated; however, some mild symptoms were observed due to the method of bradycardia determination, allowing bradycardia. Three patients were symptomatic as a direct result of the algorithm operation, and four patients had symptoms related to the single chamber operation of the pacemaker while functioning in the diagnosis mode (VDI). These symptoms were relieved with DDD pacing.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N